Company News, Regulations

PASS Supports FDA’s OTC Monograph Review

Urges Administration to act on pending sunscreen applications.

Author Image

By: TOM BRANNA

Editor

The Public Access to SunScreens (PASS) Coalition supports the Food and Drug Administration's newly scheduled March public meeting to obtain input on the Over-The-Counter, (OTC) Monograph Drug Review. However the coalition was quick to point out that while these efforts are necessary for revising the OTC monograph system in general, the FDA needs to do more to address the urgent public health need so that the American consumer has access to the latest, innovative sunscreen ingredients.   PAS...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters

Topics